NewsBenzinga앨러리티 테라퓨틱스, 사내 의료 연구소의 역량을 프로테오믹스 및 세포주 연구로 확대 앨러리티 테라퓨틱스, 사내 의료 연구소의 역량을 프로테오믹스 및 세포주 연구로 확대 Benzinga 2026.09.28 12:01 (GMT+0) Open on Benzinga Other news Boeing Stock: The Real Test Of Its Recovery Begins Now (NYSE:BA) Arbitrum Launches USDG Stablecoin Growth Program with 2 Million ARB Reward Pool Sony: The Hardware Cycle Is Hiding A Better Earnings Mix (NYSE:SONY) Anthropic privately pitches its own AI safety bill to lawmakers Apple Hires Meta Veteran Scott Tucker to Lead Global Litigation and Financial Services Legal Affairs Citizens Financial Group, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:CFG) 2026-10-17
